The total number of 476 interpretabletumors for MUC5AC was sufficient to find significant differences in the MUC5ACpositivity between pancreatic cancers and ampulla Vateri cancers, and to excludesignificant association with parameters of tumor aggressiveness or microsatellitestatus within these subsets. This evidence concerns the gene MUC5AC and pancreatic neoplasm.